ClinicalTrials.Veeva

Menu

Nasal Packing as a Drug Delivery System Postoperatively in Chronic Sinusitis With Polyposis

University of Michigan logo

University of Michigan

Status and phase

Completed
Phase 3

Conditions

Chronic Sinusitis
Polyposis

Treatments

Drug: pulmicort

Study type

Interventional

Funder types

Other

Identifiers

NCT01197612
HUM00029273

Details and patient eligibility

About

That high-dose steroid applied to the nasal cavity immediately post-operatively will improve olfaction and healing following endoscopic sinus surgery.

Enrollment

23 patients

Sex

All

Ages

18 to 99 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • hyposmia and nasal obstruction for >12 weeks
  • bilateral nasal polyposis
  • candidate for surgery

Exclusion criteria

  • immunocompromised
  • non-English speaking
  • prisoner
  • pregnant/lactating
  • will not attend follow up appointments

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

Triple Blind

23 participants in 1 patient group

Single Arm; nostrils as experimental and comparator
Other group
Description:
each subject serves as their own control with one nostril being treated with pulmicort and one not
Treatment:
Drug: pulmicort

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems